|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Roferon-A (Interferon Alfa-2A). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (38)
Cases resulting in a serious event (38)
Cases resulting in death (3)
Cases resulting in hospitalization (25)
Cases resulting in disability (5)
Cases resulting in other serious reactions (15)
Below is a sample of reports where side effects / adverse reactions may be related to Roferon-A (Interferon Alfa-2A). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in 63 year old male receiving Roferon-A (Interferon Alfa-2A)
Reported by a physician from France on 2007-10-19
Patient: 63 year old male
Adverse reactions / side effects: Myoclonus, Neoplasm Malignant
Adverse event resulted in: death
Suspect drug(s):
Roferon-A (Interferon Alfa-2A)
Other drugs received by patient: Clonazepam; Valproate Sodium
Adverse event in female receiving Roferon-A (Interferon Alfa-2A)
Reported by a physician from Germany on 2007-10-09
Patient: female
Adverse reactions / side effects: Thermal Burn
Suspect drug(s):
Roferon-A
Puvasoralen
Dosage: systemic puva (psoralens plus uv-a) therapy
Adverse event in female receiving Roferon-A (Interferon Alfa-2A)
Reported by a physician from Germany on 2007-10-08
Patient: female
Adverse reactions / side effects: Basedow's Disease
Suspect drug(s):
Roferon-A (Interferon Alfa-2A)
Adverse event in 23 year old male receiving Roferon-A (Interferon Alfa-2A)
Reported by a health professional (non-physician/pharmacist) from Turkey on 2007-10-02
Patient: 23 year old male
Adverse reactions / side effects: Guillain-Barre Syndrome
Adverse event resulted in: hospitalization
Suspect drug(s):
Roferon-A (Interferon Alfa-2A)
Adverse event in 55 year old female receiving Roferon-A (Interferon Alfa-2A)
Reported by a pharmacist from Germany on 2007-07-12
Patient: 55 year old female, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Grand MAL Convulsion, HIP Surgery
Adverse event resulted in: hospitalization
Suspect drug(s):
Roferon-A (Interferon Alfa-2A)
Other drugs received by patient: Valoron; Diclofenac Sodium
Adverse event in male receiving Roferon-A (Interferon Alfa-2A)
Reported by a consumer/non-health professional from Germany on 2007-07-09
Patient: male
Adverse reactions / side effects: Haematology Test Abnormal, Fatigue, Restlessness, Seminoma, Headache
Suspect drug(s):
Roferon-A
Dosage: form reported as syringe.
Indication: Malignant Melanoma
Start date: 2007-02-23
Roferon-A
Dosage: form reported as pen.
Adverse event in receiving Roferon-A (Interferon Alfa-2A)
Reported by a physician from Germany on 2007-07-06
Patient:
Adverse reactions / side effects: Lipase Increased
Suspect drug(s):
Roferon-A (Interferon Alfa-2A)
Adverse event in 60 year old female receiving Roferon-A (Interferon Alfa-2A)
Reported by a physician from Austria on 2007-06-29
Patient: 60 year old female, weighing 72.0 kg (158.4 pounds)
Adverse reactions / side effects: Renal Colic, Urinary Tract Infection
Adverse event resulted in: hospitalization
Suspect drug(s):
Isotretinoin
Administration route: Oral
Indication: Malignant Melanoma
Start date: 1997-11-17
End date: 1998-09-10
Roferon-A
Indication: Malignant Melanoma
Start date: 1997-11-17
End date: 1999-08-30
Adverse event in 45 year old female receiving Roferon-A (Interferon Alfa-2A)
Reported by a physician from Austria on 2007-06-29
Patient: 45 year old female, weighing 67.0 kg (147.4 pounds)
Adverse reactions / side effects: Basal Cell Carcinoma, Erysipelas
Adverse event resulted in: hospitalization
Suspect drug(s):
Roferon-A
Indication: Malignant Melanoma
Start date: 1998-02-27
End date: 2000-03-24
Placebo
Administration route: Oral
Indication: Malignant Melanoma
Start date: 1998-02-27
End date: 2000-03-24
Adverse event in 44 year old male receiving Roferon-A (Interferon Alfa-2A)
Reported by a physician from Austria on 2007-06-29
Patient: 44 year old male, weighing 105.0 kg (231.0 pounds)
Adverse reactions / side effects: Testicular Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Roferon-A
Indication: Malignant Melanoma
Start date: 1997-01-08
Placebo
Administration route: Oral
Indication: Malignant Melanoma
Start date: 1997-01-08
Adverse event in female receiving Roferon-A (Interferon Alfa-2A)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-17
Patient: female, weighing 75.0 kg (165.0 pounds)
Adverse reactions / side effects: Fatigue, Vomiting, Diarrhoea, Nausea, Anorexia, Dehydration, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Roferon-A
Dosage: 6 million iu,sq,x6 tota
Indication: Colon Cancer
Start date: 2004-04-30
Roferon-A
Dosage: 6 million iu,sq,x6 tota
Indication: Colon Cancer
Start date: 2007-04-07
Roferon-A
Dosage: 6 million iu,sq,x6 tota
Indication: Colon Cancer
Start date: 2007-04-24
Roferon-A
Dosage: 6 million iu,sq,x6 tota
Indication: Colon Cancer
Start date: 2007-04-26
Roferon-A
Dosage: 6 million iu,sq,x6 tota
Indication: Colon Cancer
Start date: 2007-04-28
Roferon-A
Dosage: 6 million iu,sq,x6 tota
Indication: Colon Cancer
Start date: 2007-05-02
Adverse event in 55 year old female receiving Roferon-A (Interferon Alfa-2A)
Reported by a pharmacist from Germany on 2007-05-07
Patient: 55 year old female, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: HIP Surgery, Convulsion
Adverse event resulted in: hospitalization
Suspect drug(s):
Roferon-A (Interferon Alfa-2A)
Other drugs received by patient: Valoron; Diclofenac
Adverse event in 55 year old female receiving Roferon-A (Interferon Alfa-2A)
Reported by a pharmacist from Germany on 2007-04-20
Patient: 55 year old female
Adverse reactions / side effects: HIP Surgery, Convulsion
Adverse event resulted in: hospitalization
Suspect drug(s):
Roferon-A (Interferon Alfa-2A)
Other drugs received by patient: Valoron; Diclofenac
Adverse event in receiving Roferon-A (Interferon Alfa-2A)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-04-19
Patient:
Adverse reactions / side effects: Retinal Detachment
Suspect drug(s):
Roferon-A (Interferon Alfa-2A)
Adverse event in 55 year old female receiving Roferon-A (Interferon Alfa-2A)
Reported by a pharmacist from Germany on 2007-04-17
Patient: 55 year old female
Adverse reactions / side effects: Procedural Pain, Epilepsy, HIP Surgery
Suspect drug(s):
Roferon-A (Interferon Alfa-2A)
Other drugs received by patient: Valoron; Diclofenac
Adverse event in 71 year old male receiving Roferon-A (Interferon Alfa-2A)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-04-12
Patient: 71 year old male
Adverse reactions / side effects: Drug Administration Error, Collapse of Lung, Ascites, Disease Progression
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Roferon-A (Interferon Alfa-2A)
Adverse event in 56 year old female receiving Roferon-A (Interferon Alfa-2A)
Reported by a physician from Austria on 2007-04-10
Patient: 56 year old female, weighing 86.0 kg (189.2 pounds)
Adverse reactions / side effects: Nephrolithiasis, Urosepsis
Adverse event resulted in: hospitalization
Suspect drug(s):
Roferon-A
Indication: Malignant Melanoma
Start date: 1997-08-06
End date: 1999-05-25
Placebo
Administration route: Oral
Indication: Malignant Melanoma
Start date: 1997-08-06
End date: 1999-05-25
Adverse event in 61 year old female receiving Roferon-A (Interferon Alfa-2A)
Reported by a physician from Austria on 2007-04-10
Patient: 61 year old female, weighing 50.0 kg (110.0 pounds)
Adverse reactions / side effects: Metastases TO Lymph Nodes
Adverse event resulted in: hospitalization
Suspect drug(s):
Roferon-A
Indication: Malignant Melanoma
Start date: 2000-03-17
End date: 2000-07-14
Placebo
Administration route: Oral
Indication: Malignant Melanoma
Start date: 2000-03-17
End date: 2000-07-14
Other drugs received by patient: Urosin; Tenoretic 100
Adverse event in 60 year old female receiving Roferon-A (Interferon Alfa-2A)
Reported by a physician from Austria on 2007-04-10
Patient: 60 year old female, weighing 72.0 kg (158.4 pounds)
Adverse reactions / side effects: Renal Colic, Urinary Tract Infection
Adverse event resulted in: hospitalization
Suspect drug(s):
Isotretinoin
Administration route: Oral
Indication: Malignant Melanoma
Start date: 1997-11-17
End date: 1998-09-10
Roferon-A
Indication: Malignant Melanoma
Start date: 1997-11-17
End date: 1999-08-30
Adverse event in 61 year old female receiving Roferon-A (Interferon Alfa-2A)
Reported by a physician from Austria on 2007-04-10
Patient: 61 year old female, weighing 50.0 kg (110.0 pounds)
Adverse reactions / side effects: Metastases TO Lymph Nodes
Adverse event resulted in: hospitalization
Suspect drug(s):
Roferon-A
Indication: Malignant Melanoma
Start date: 2000-03-17
End date: 2000-07-14
Placebo
Administration route: Oral
Indication: Malignant Melanoma
Start date: 2000-03-17
End date: 2000-07-14
Other drugs received by patient: Urosin; Tenoretic 100
Adverse event in 54 year old male receiving Roferon-A (Interferon Alfa-2A)
Reported by a physician from Austria on 2007-04-10
Patient: 54 year old male, weighing 92.0 kg (202.4 pounds)
Adverse reactions / side effects: Facial Paresis, Malignant Melanoma
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Isotretinoin
Administration route: Oral
Indication: Malignant Melanoma
Start date: 1998-12-21
End date: 2000-06-24
Roferon-A
Indication: Malignant Melanoma
Start date: 1998-12-21
End date: 2000-06-24
Adverse event in 45 year old female receiving Roferon-A (Interferon Alfa-2A)
Reported by a physician from Austria on 2007-04-09
Patient: 45 year old female, weighing 67.0 kg (147.4 pounds)
Adverse reactions / side effects: Basal Cell Carcinoma, Erysipelas
Adverse event resulted in: hospitalization
Suspect drug(s):
Roferon-A
Indication: Malignant Melanoma
Start date: 1998-02-27
End date: 2000-03-24
Placebo
Administration route: Oral
Indication: Malignant Melanoma
Start date: 1998-02-27
End date: 2000-03-24
Adverse event in 44 year old male receiving Roferon-A (Interferon Alfa-2A)
Reported by a physician from Austria on 2007-04-09
Patient: 44 year old male, weighing 105.0 kg (231.0 pounds)
Adverse reactions / side effects: Testicular Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Roferon-A
Indication: Malignant Melanoma
Start date: 1997-01-08
Placebo
Administration route: Oral
Indication: Malignant Melanoma
Start date: 1997-01-08
Adverse event in 75 year old female receiving Roferon-A (Interferon Alfa-2A)
Reported by a physician from Germany on 2007-03-27
Patient: 75 year old female
Adverse reactions / side effects: Liver Function Test Abnormal, Hepatic Steatosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Roferon-A
Start date: 2006-08-15
End date: 2006-11-15
Meloxicam
Katadolon
Unspecified Drug
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Antihypotensive Agents
Adverse event in 75 year old female receiving Roferon-A (Interferon Alfa-2A)
Reported by a physician from Germany on 2007-03-27
Patient: 75 year old female
Adverse reactions / side effects: Liver Function Test Abnormal, Hepatic Steatosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Roferon-A
Start date: 2006-08-15
End date: 2006-11-15
Meloxicam
Katadolon
Unspecified Drug
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Antihypotensive Agents
|
